Congratulations to Mayo Clinic & Illinois Alliance researchers Professor Brendan Harley (Illinois), Ian Parney (Mayo), Jann Sarkaria (Mayo), and Steven George, a collaborator from Washington University in St. Louis, who have been awarded R01 funding from the National Institutes of Health for their project titled, "Biomimetic hydrogel niches to study the malignant phenotype of glioblastoma multiforme."
Following a Biomarker Discovery Workshop in 2014, hosted by the Mayo Clinic and Illinois Alliance, Brendan Harley, Jann Sarkaria, and Daniel Ma (Mayo) submitted a proposal for a clinical and translational project. Their project, "Chip-based engineered tumor microenvironments for glioma therapy" was one of four chosen to receive seed funding from the Mayo Clinic and University of Illinois. Two years later, their research is now sponsored by the NIH for the next five years.
Brendan Harley is the PI on this awarded research project, which you can read more about here. For more information about the Mayo Clinic & Illinois Alliance, contact IHSI research development specialist Maggie Miller.